Status:
COMPLETED
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
Lead Sponsor:
California Pacific Medical Center Research Institute
Conditions:
Methamphetamine Addiction
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the safety and effectiveness dextroamphetamine to help methamphetamine users quit or cut down on their use. The study lasts for 9 weeks. Eligible participants wi...
Eligibility Criteria
Inclusion
- 18-50 yrs. old
Exclusion
- pregnant or lactating females
- Contact site for additional information
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00630682
Start Date
September 1 2006
End Date
August 1 2011
Last Update
June 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CPMC-St. Luke's Campus-Addiction Pharmacology Research Laboratory
San Francisco, California, United States, 94110